Pacer Advisors Inc. Sells 10,712 Shares of CME Group Inc. $CME

Pacer Advisors Inc. lessened its stake in CME Group Inc. (NASDAQ:CME) by 32.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,136 shares of the financial services provider’s stock after selling 10,712 shares during the quarter. Pacer Advisors Inc.’s holdings in CME Group were worth $6,538,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Militia Capital Management LLC acquired a new position in shares of CME Group during the 1st quarter worth about $2,558,000. FAS Wealth Partners Inc. lifted its stake in CME Group by 8.1% in the 1st quarter. FAS Wealth Partners Inc. now owns 16,578 shares of the financial services provider’s stock valued at $4,896,000 after purchasing an additional 1,236 shares during the last quarter. NewEdge Advisors LLC lifted its stake in CME Group by 12.9% in the 1st quarter. NewEdge Advisors LLC now owns 67,317 shares of the financial services provider’s stock valued at $19,882,000 after purchasing an additional 7,672 shares during the last quarter. First Nebraska Trust Co acquired a new stake in CME Group in the 1st quarter valued at about $577,000. Finally, Keel Point LLC grew its holdings in CME Group by 3.6% during the first quarter. Keel Point LLC now owns 1,510 shares of the financial services provider’s stock worth $446,000 after purchasing an additional 52 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Up 0.8%

CME Group stock opened at $264.78 on Thursday. The stock has a market cap of $95.21 billion, a P/E ratio of 22.46, a P/E/G ratio of 3.06 and a beta of 0.23. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company’s 50-day moving average price is $249.70 and its two-hundred day moving average price is $281.01.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the previous year, the company posted $2.96 earnings per share. The business’s revenue was up .8% on a year-over-year basis. As a group, analysts expect that CME Group Inc. will post 12.27 EPS for the current year.

Analysts Set New Price Targets

CME has been the topic of several research analyst reports. JPMorgan Chase & Co. upped their price objective on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday, July 23rd. Wall Street Zen lowered CME Group from a “sell” rating to a “strong sell” rating in a report on Saturday, August 1st. Deutsche Bank Aktiengesellschaft dropped their price target on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research note on Thursday, April 23rd. Jefferies Financial Group cut their price target on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Finally, Piper Sandler reduced their price objective on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research report on Wednesday, July 15th. Eleven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $291.81.

Insider Buying and Selling

In related news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares of the company’s stock, valued at $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.